Achievements
-
.68mcourses of SMC
delivered to countries in the Sahel in 2017, enough to protect 17 million children
-
.18,000health-care workers
across 2,082 health-care facilities trained to administer injectable artesunate for severe malaria
-
.127mvials
of injectable artesunate for severe malaria delivered since 2010, saving the lives of an estimated 800,000 additional vulnerable children compared with quinine treatment
Defeating malaria together
Featured resources
-
The life-saving benefits of pre-referral management
Apr 2019 -
Plasmodium knowlesi exhibits distinct in vitro drug susceptibility profiles from those of Plasmodium falciparum
Apr 2019 -
African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker
Apr 2019
Events
-
12May
Wellcome Centre for Anti-Infectives Research Conference 2019
12-15 May 2019University of Dundee, UK -
24May
Celebrating a 10 year collaboration in malaria drug discovery
24 May 2019Cape Town, South Africa -
26Jun
7th International Conference on Plasmodium vivax Research (ICPvR)
26-28 JuneParis, France